This precautionary approach exists because animal studies have shown potential risks to foetal development, although human pregnancy data remains limited
Over time, it may help prevent or improve medical conditions linked to low B12 levels, such as anemia and nerve damage
The Semaglutide pen is designed for ease of use
Future triple agonists targeting GLP-1, GIP, and glucagon receptors simultaneously are in late-stage development at multiple companies and could potentially offer additional efficacy advantages over semaglutide by the late 2020s
GLP-1 enhances insulin secretion from the pancreas, reduces hunger, and increases the feeling of fullness by delaying gastric emptying
$495.00 $175.00/mo* GLP-1 (Sema) Tablets Compounded GLP-1 fast disolving tablets - mimics GLP-1 to reduce appetite, slow digestion, and support fat loss